Be Ready to Help Your Crohn's Disease Patients Start Biologics

You'll see biologics considered earlier for Crohn's disease...partly due to new guidelines from the Am College of Gastroenterology.

This "top-down" approach is becoming more popular...versus waiting to see if meds such as sulfasalazine, mesalamine, or corticosteroids help.

For Crohn's, anticipate seeing infliximab (Remicade), adalimumab (Humira), certolizumab (Cimzia), vedolizumab (Entyvio), etc. These can lead to faster and longer-lasting remission for some higher-risk patients.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote